フィブリンシーラントの世界市場レポート 2025年

フィブリンシーラント市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.1％で16億1,000万米ドルに成長します。予測期間の成長は、美容整形手術の増加、老年人口の増加、CABGの増加、血液関連疾患の増加、歯科手術の増加などに起因しています。予測期間における主な動向としては、技術の進歩、高度な止血技術、個別化医療、デジタルヘルス技術、ロボット支援手術などが挙げられます。

フィブリンシーラント市場の成長は、美容外科手術の増加によって牽引されると予測されます。美容整形手術は、個人の外見の向上や変更に重点を置くもので、美的感覚への社会の注目、手術技術の進歩、低侵襲手術へのアクセスの向上により増加傾向にあります。フィブリンシーラントは、創傷治癒を早め、出血を抑え、瘢痕を最小限にすることで、手術結果と患者の回復を改善する美容外科手術に使用されています。例えば、CosmetAssure社が2023年9月に報告したところによると、脂肪吸引は2023年に最も人気のある美容整形手術で、34万7,782件の手術が行われ、2022年から7％増加しました。さらに、タミータックは5％増加し、17万110件の手術が行われました。このような美容外科手術の増加がフィブリンシーラントの需要を押し上げています。

フィブリンシーラント市場の各社は、接触による出血を迅速に抑制する止血剤を開発しています。止血剤は、創傷部位や手術部位で血液凝固を促して出血を止めるために使用される物質です。例えば、2022年2月、インドを拠点とする止血剤メーカーSwasth Kare社は、同じくインドを拠点とするWortham Laboratories社が開発したSeraSealを発表しました。セラシールはフィブリンシーラントで、動脈性出血の場合でもほぼ瞬時に止血できるように設計されています。その迅速な作用は緊急時に極めて重要であり、半透明であるため、外科医は出血部位をはっきりと確認することができ、手技中のより良い意思決定に役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界フィブリンシーラント PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のフィブリンシーラント市場：成長率分析
• 世界のフィブリンシーラント市場の実績：規模と成長, 2019-2024
• 世界のフィブリンシーラント市場の予測：規模と成長, 2024-2029, 2034F
• 世界フィブリンシーラント総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のフィブリンシーラント市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体
• パッチ
• 粉
• 世界のフィブリンシーラント市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己血提供
• ウイルス不活化
• 組み換え生産
• その他のテクノロジー
• 世界のフィブリンシーラント市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一般外科
• 心臓血管外科
• 創傷管理
• 整形外科
• 泌尿器科手術
• 眼科手術
• 移植手術
• その他の用途
• 世界のフィブリンシーラント市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• その他のエンドユーザー
• 世界のフィブリンシーラント市場、液体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛由来液体シーラント
• ヒト由来液体シーラント
• 合成液体シーラント
• 組み換えフィブリンシーラント
• 世界のフィブリンシーラント市場、パッチのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛由来フィブリンパッチ
• ヒト由来フィブリンパッチ
• 合成フィブリンパッチ
• 生体吸収性フィブリンパッチ
• 世界のフィブリンシーラント市場、粉末の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛由来フィブリン粉末
• ヒト由来フィブリン粉末
• 合成フィブリン粉末
• 組換えフィブリン粉末

第7章 地域別・国別分析

• 世界のフィブリンシーラント市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のフィブリンシーラント市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• フィブリンシーラント市場：競合情勢
• フィブリンシーラント市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Asahi Kasei Medical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • CSL Behring Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Grifols S.A.
• Sigma-Aldrich
• Nordson Corporation
• Integra LifeSciences Corporation
• Shanghai RAAS Blood Products Co. Ltd.
• Mallinckrodt Pharmaceuticals
• Biotest AG
• LFB Group
• Hualan Biological Engineering Inc.
• Corza Medical
• Aesculap Inc.
• Ethicon Inc.
• CryoLife Inc.
• VIVEX Biologics Inc.
• MediWound Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• フィブリンシーラント市場2029：新たな機会を提供する国
• フィブリンシーラント市場2029：新たな機会を提供するセグメント
• フィブリンシーラント市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Fibrin sealants, also known as fibrin glues or fibrin tissue adhesives, are specialized medical products used to facilitate blood clotting and tissue healing. They consist of two key components derived from human or animal blood, fibrinogen, a protein involved in blood clot formation, and thrombin, an enzyme that converts fibrinogen into fibrin, the primary substance in blood clots. These sealants are commonly employed during surgeries to manage bleeding, particularly in delicate or difficult-to-reach areas where traditional methods such as sutures or cauterization may not be effective.

The main types of fibrin sealants include liquid, patch, and powder forms. Liquid fibrin sealants are solutions of fibrinogen and thrombin that, when mixed, form a fibrin clot. These sealants are applied during surgical procedures to control bleeding and enhance tissue adhesion, with methods of application such as dripping or spraying for precise delivery to the affected area. Technologies used in the production of fibrin sealants include autologous donation, viral inactivation, and recombinant production, among others. Fibrin sealants are used in a variety of applications, including general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgeries, ophthalmic surgeries, and transplant surgery, and are utilized in hospitals, ambulatory surgical centers, and other healthcare facilities.

The fibrin sealants market research report is one of a series of new reports from The Business Research Company that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fibrin sealants market size has grown strongly in recent years. It will grow from $1.08 $ billion in 2024 to $1.17 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growth in medical tourism, growth in healthcare infrastructure, rise in elective surgical procedures, increasing prevalence of chronic diseases, and rise in demand for rapid hemostasis solutions.

The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.61 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing number of cosmetic surgeries, increasing geriatric population, increasing number of CABG, increasing blood-related disorders, and rising number of dental surgeries. Major trends in the forecast period include technological advancements, advanced hemostatic technologies, personalized medicine, digital health technologies, and robotic-assisted surgeries.

The growth of the fibrin sealants market is anticipated to be driven by the increasing number of cosmetic surgeries. Cosmetic surgeries, which focus on enhancing or altering an individual's appearance, are on the rise due to societal focus on aesthetics, advancements in surgical techniques, and greater access to minimally invasive procedures. Fibrin sealants are used in cosmetic surgeries to promote quicker wound healing, reduce bleeding, and minimize scarring, thereby improving surgical outcomes and patient recovery. For example, CosmetAssure reported in September 2023 that liposuction was the most popular plastic surgery procedure in 2023, with 347,782 procedures performed, reflecting a 7% increase from 2022. Additionally, tummy tucks saw a 5% rise, with 170,110 procedures carried out. This increase in cosmetic surgeries is boosting the demand for fibrin sealants.

Companies in the fibrin sealants market are developing hemostatic agents to rapidly control bleeding upon contact. Hemostatic agents are substances used to stop bleeding by encouraging blood clotting at wound or surgical sites. For instance, in February 2022, Swasth Kare, an India-based manufacturer of hemostatic agents, introduced SeraSeal, developed by Wortham Laboratories, also based in India. SeraSeal is a fibrin sealant designed to stop bleeding almost instantly, even in cases of arterial hemorrhage. Its rapid action is crucial in emergencies, and its translucent quality allows surgeons to clearly see the bleeding site, aiding in better decision-making during procedures.

In July 2024, Corza Medical, a US-based company specializing in innovative surgical technologies, acquired Takeda's TachoSil Manufacturing Operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to enhance service levels and global customer support. Takeda, a pharmaceutical company based in Japan, is involved in the development and production of fibrin sealants.

Major players in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., and Cohesion Technologies Inc.

North America was the largest region in the fibrin sealants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibrin sealants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fibrin Sealants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fibrin sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fibrin sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fibrin sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Liquid; Patch; Powder
• 2) By Technology: Autologous Donation; Viral Inactivation; Recombinant Production; Other Technologies
• 3) By Application: General Surgery; Cardiovascular Surgery; Wound Management; Orthopedic Surgery; Urological Surgeries; Ophthalmic Surgeries; Transplant Surgery; Other Applications
• 4) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Liquid: Bovine-Derived Liquid Sealants; Human-Derived Liquid Sealants; Synthetic Liquid Sealants; Recombinant Fibrin Sealants
• 2) By Patch: Bovine-Derived Fibrin Patches; Human-Derived Fibrin Patches; Synthetic Fibrin Patches; Bioabsorbable Fibrin Patches
• 3) By Powder: Bovine-Derived Fibrin Powder; Human-Derived Fibrin Powder; Synthetic Fibrin Powder; Recombinant Fibrin Powder
• Companies Mentioned: Johnson & Johnson; Takeda Pharmaceutical Company Limited; Asahi Kasei Medical Co. Ltd.; Baxter International Inc.; CSL Behring
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fibrin Sealants Market Characteristics

3. Fibrin Sealants Market Trends And Strategies

4. Fibrin Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fibrin Sealants Growth Analysis And Strategic Analysis Framework

• 5.1. Global Fibrin Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Fibrin Sealants Market Growth Rate Analysis
• 5.4. Global Fibrin Sealants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Fibrin Sealants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Fibrin Sealants Total Addressable Market (TAM)

6. Fibrin Sealants Market Segmentation

• 6.1. Global Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid
• Patch
• Powder
• 6.2. Global Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Donation
• Viral Inactivation
• Recombinant Production
• Other Technologies
• 6.3. Global Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• General Surgery
• Cardiovascular Surgery
• Wound Management
• Orthopedic Surgery
• Urological Surgeries
• Ophthalmic Surgeries
• Transplant Surgery
• Other Applications
• 6.4. Global Fibrin Sealants Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Other End-Users
• 6.5. Global Fibrin Sealants Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine-Derived Liquid Sealants
• Human-Derived Liquid Sealants
• Synthetic Liquid Sealants
• Recombinant Fibrin Sealants
• 6.6. Global Fibrin Sealants Market, Sub-Segmentation Of Patch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine-Derived Fibrin Patches
• Human-Derived Fibrin Patches
• Synthetic Fibrin Patches
• Bioabsorbable Fibrin Patches
• 6.7. Global Fibrin Sealants Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine-Derived Fibrin Powder
• Human-Derived Fibrin Powder
• Synthetic Fibrin Powder
• Recombinant Fibrin Powder

7. Fibrin Sealants Market Regional And Country Analysis

• 7.1. Global Fibrin Sealants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Fibrin Sealants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fibrin Sealants Market

• 8.1. Asia-Pacific Fibrin Sealants Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fibrin Sealants Market

• 9.1. China Fibrin Sealants Market Overview
• 9.2. China Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fibrin Sealants Market

• 10.1. India Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fibrin Sealants Market

• 11.1. Japan Fibrin Sealants Market Overview
• 11.2. Japan Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fibrin Sealants Market

• 12.1. Australia Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fibrin Sealants Market

• 13.1. Indonesia Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fibrin Sealants Market

• 14.1. South Korea Fibrin Sealants Market Overview
• 14.2. South Korea Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fibrin Sealants Market

• 15.1. Western Europe Fibrin Sealants Market Overview
• 15.2. Western Europe Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fibrin Sealants Market

• 16.1. UK Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fibrin Sealants Market

• 17.1. Germany Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fibrin Sealants Market

• 18.1. France Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fibrin Sealants Market

• 19.1. Italy Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fibrin Sealants Market

• 20.1. Spain Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fibrin Sealants Market

• 21.1. Eastern Europe Fibrin Sealants Market Overview
• 21.2. Eastern Europe Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fibrin Sealants Market

• 22.1. Russia Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fibrin Sealants Market

• 23.1. North America Fibrin Sealants Market Overview
• 23.2. North America Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fibrin Sealants Market

• 24.1. USA Fibrin Sealants Market Overview
• 24.2. USA Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fibrin Sealants Market

• 25.1. Canada Fibrin Sealants Market Overview
• 25.2. Canada Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fibrin Sealants Market

• 26.1. South America Fibrin Sealants Market Overview
• 26.2. South America Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fibrin Sealants Market

• 27.1. Brazil Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fibrin Sealants Market

• 28.1. Middle East Fibrin Sealants Market Overview
• 28.2. Middle East Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fibrin Sealants Market

• 29.1. Africa Fibrin Sealants Market Overview
• 29.2. Africa Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fibrin Sealants Market Competitive Landscape And Company Profiles

• 30.1. Fibrin Sealants Market Competitive Landscape
• 30.2. Fibrin Sealants Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Asahi Kasei Medical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

31. Fibrin Sealants Market Other Major And Innovative Companies

• 31.1. Grifols S.A.
• 31.2. Sigma-Aldrich
• 31.3. Nordson Corporation
• 31.4. Integra LifeSciences Corporation
• 31.5. Shanghai RAAS Blood Products Co. Ltd.
• 31.6. Mallinckrodt Pharmaceuticals
• 31.7. Biotest AG
• 31.8. LFB Group
• 31.9. Hualan Biological Engineering Inc.
• 31.10. Corza Medical
• 31.11. Aesculap Inc.
• 31.12. Ethicon Inc.
• 31.13. CryoLife Inc.
• 31.14. VIVEX Biologics Inc.
• 31.15. MediWound Ltd.

32. Global Fibrin Sealants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fibrin Sealants Market

34. Recent Developments In The Fibrin Sealants Market

35. Fibrin Sealants Market High Potential Countries, Segments and Strategies

• 35.1 Fibrin Sealants Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Fibrin Sealants Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Fibrin Sealants Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer